AUC, Africa CDC, and Gavi forge strategic vaccine partnership

Through the MoU, the three organizations commit to increase access and accelerate the uptake of vaccines across African Union member states, by leveraging their collective resources, expertise and expansive networks to collaboratively address a broad range of health issues.
Senior leadership from all three organisations as well as technical experts, contributed to the action-oriented sessions, which were aligned across the following cross-cutting issues:
- Fostering sustainable and equitable systems for immunisation, including reaching zero-dose children, overcoming barriers, and building a resilient health workforce.
- Building public trust and confidence in immunisation, including demand generation and social behavioural change, and aligning immunisation-related communications and advocacy.
- Realising the continental vision to expand vaccine manufacturing in Africa, including the facilitation of efficient regulatory pathways and timely authorisations of vaccines and efficient, effective pharmacovigilance.
- Strengthening diagnostic and disease surveillance capacity for epidemic-prone vaccine-preventable diseases.
In addition to these discussions, the delegations also engaged in preliminary discussions on the design of Gavi’s next five-year strategic period, “Gavi 6.0”, which will run from 2026 to 2030, as well as ways to align on pandemic prevention, preparedness and response activities.
The AUC and Africa CDC delegation was led by Ahmed Ogwell Ouma, acting deputy director general of Africa CDC. Gavi’s delegation was led by Pascal Barollier, chief engagement officer and Thabani Maphosa, managing director of the country programmes delivery.
"We have come together to give life to the tripartite MoU and to secure the health of the continent of Africa. We have committed to work in synergy and give Africa tangible results for immunisation in the shortest time," said Ouma.
“The work our organisations undertake is intrinsically linked, and it is critical that we have come together in service of the AUC’s continental vision for public health, the new public health order,” said Maphosa. “This week’s workshop was the time to turn our deep commitment to collaboration into a tangible plan of action.
“Gavi is proud to be a partner to the African Union Commission and Africa CDC, and we are excited to be expanding this partnership into so many aspects of our work.”
Related
Africa's top health official presses US to resume health aid 6 Feb 2025 African CDC: More than $800m pledged for mpox response 27 Sep 2024 Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic 19 Sep 2024 Africa CDC confident it can raise $600m for mpox response 17 Sep 2024 WHO clears Bavarian Nordic's vaccine for mpox, sets up access scheme 16 Sep 2024 Mpox: No global lockdowns, emphasis on increased education, vigilance, airport screening and monitoring 24 Aug 2024 Health Department: Mpox under control, stay vigilant 21 Aug 2024 Gavi and Unicef welcome approval of new oral cholera vaccine 23 Apr 2024